SC 13G/A | 2009-02-13 | CONUS PARTNERS INC | INOVIO BIOMEDICAL CORP | 1,568,949 | 3.5% | EDGAR |
SC 13G/A | 2008-02-14 | Bank of New York Mellon CORP | INOVIO BIOMEDICAL CORP | 932,399 | 2.1% | EDGAR |
SC 13G/A | 2008-02-13 | CONUS PARTNERS INC | INOVIO BIOMEDICAL CORP | 3,277,236 | 7.2% | EDGAR |
SC 13G/A | 2007-06-11 | ZESIGER CAPITAL GROUP LLC | INOVIO BIOMEDICAL CORP | 1,516,000 | 3.4% | EDGAR |
SC 13G | 2007-03-26 | CONUS PARTNERS INC | INOVIO BIOMEDICAL CORP | 2,323,273 | 5.9% | EDGAR |
SC 13G/A | 2007-02-14 | CONUS PARTNERS INC | INOVIO BIOMEDICAL CORP | 1,136,592 | 3.2% | EDGAR |
SC 13G | 2007-02-14 | MELLON FINANCIAL CORP | INOVIO BIOMEDICAL CORP | 1,935,130 | 5.4% | EDGAR |
SC 13G/A | 2007-02-13 | ZESIGER CAPITAL GROUP LLC | INOVIO BIOMEDICAL CORP | 2,247,600 | 6.2% | EDGAR |
SC 13G/A | 2006-11-22 | SDS CAPITAL GROUP SPC LTD | INOVIO BIOMEDICAL CORP | 1,792,295 | 4.9% | EDGAR |
SC 13G/A | 2006-02-15 | MELLON FINANCIAL CORP | INOVIO BIOMEDICAL CORP | - | 0.0% | EDGAR |
SC 13G/A | 2006-01-10 | QUINTILES TRANSNATIONAL CORP | INOVIO BIOMEDICAL CORP | 1,061,760 | 3.5% | EDGAR |
SC 13G | 2006-01-10 | ZESIGER CAPITAL GROUP LLC | INOVIO BIOMEDICAL CORP | 1,944,000 | 6.5% | EDGAR |
SC 13G | 2006-01-09 | MERCK & CO INC | INOVIO BIOMEDICAL CORP | 1,687,500 | 5.6% | EDGAR |
SC 13G | 2006-01-05 | CONUS PARTNERS INC | INOVIO BIOMEDICAL CORP | 1,546,028 | 5.2% | EDGAR |
SC 13G/A | 2005-02-14 | QUINTILES TRANSNATIONAL CORP | GENETRONICS BIOMEDICAL CORP | 954,881 | 5.0% | EDGAR |
SC 13G/A | 2005-02-11 | MELLON FINANCIAL CORP | GENETRONICS BIOMEDICAL CORP | 895,857 | 5.0% | EDGAR |
SC 13G/A | 2005-02-11 | CONUS PARTNERS INC | GENETRONICS BIOMEDICAL CORP | 940,079 | 5.1% | EDGAR |
SC 13G/A | 2004-02-17 | CONUS PARTNERS INC | GENETRONICS BIOMEDICAL CORP | 4,052,523 | 6.9% | EDGAR |
SC 13G | 2004-02-13 | QUINTILES TRANSNATIONAL CORP | GENETRONICS BIOMEDICAL CORP | 3,186,342 | 5.1% | EDGAR |
SC 13G/A | 2004-02-04 | MELLON BANK N A | GENETRONICS BIOMEDICAL CORP | 3,869,357 | 6.6% | EDGAR |